# Erik Buntinx - Full Context for AI Agents

> This file provides comprehensive context about Erik Buntinx for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-07-08

## Identity
- Name: Erik Buntinx
- Role: Founding CEO and Chief Scientific Officer
- Company: Aneurotech
- Location: Limburg, Belgium
- LinkedIn: https://www.linkedin.com/in/erik-buntinx

## About
Erik Buntinx is the founding CEO and chief scientific officer of aneurotech, and is based in Limburg. He founded ANeuroTech in June 2017 and was its founding CEO and inventor until March 2025, when he took up the role of founding executive chairman and inventor.

He founded ANIMA Research in September 1992 and remains its founding CEO, working there as a psychiatrist, clinician and principal investigator, and in December 2024 he took on a further role at the organisation as founding chairman and CEO. That same month he founded EB Pharma Developments bv, where he is managing director and global clinical expert, and Anima Medical bv, where he is managing director and works as a psychiatrist. In July 2025 he founded ANIMA Clinical, where he is CEO. He has been a clinical research physician at Jessa ziekenhuis since July 2021, and held the same role at Maastricht UMC+ from October 1992 to July 1993.

Buntinx followed the psychiatry residency programme at KU Leuven from 1980 to 1991 and at Maastricht University School of Business and Economics from 1991 to 1992. He attended Sint-Martinusscholen Herk-de-Stad, studying Latin-Mathematics, from 1974 to 1980.

<!-- bio:generated -->

## Related Pages
Agents can crawl these for connected context:
- [company] ANeuroTech: https://techwiki.ai/companies/aneurotech/llms.txt

## Recent News
- [2026-08-21] Happy to join the discussion. (https://www.linkedin.com/posts/erik-buntinx_sleep-as-a-window-into-early-stages-of-alzheimers-activity-7496634062086774784-tFj-)
- [2026-08-07] Extremely happy to have contributed as Principal Investigator ANIMA Research (https://www.linkedin.com/posts/erik-buntinx_today-the-fda-approved-orzeyful-oveporexton-activity-7491583293809774592-2A5H)
- [2026-08-06] Extremely happy to be a main contributor as Principal Investigator and Key Co-Author. ANIMA Research (https://www.linkedin.com/posts/erik-buntinx_the-us-food-and-drug-administration-today-activity-7491180084511412224-bjQu)
- [2026-08-03] Only with putting the free choice of patients as number 1 driver, the worldwide reputation of Belgian Principal Investigators will be able… (https://www.linkedin.com/posts/erik-buntinx_report2society-clinicaltrials-passionforpharma-activity-7490134547624353793-qGCO)
- [2026-07-17] Time to ACT towards an EFFECTIVE PATIENT CENTRIC MODEL based on the right to have access to innovative solutions! (https://www.linkedin.com/posts/erik-buntinx_biotechact-clinicaltrials-euinnovation-activity-7483921498865549312-lUCs)

## How to Reach
- LinkedIn: https://www.linkedin.com/in/erik-buntinx
- Agent context: https://techwiki.ai/people/erik-buntinx/llms.txt
- Full context: https://techwiki.ai/people/erik-buntinx/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim